SCHEMBL15528570

SCHEMBL15528570

COC(=O)c1ccccc1NC(=O)C1CCCCC1

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 11/20 0.97
▸ ALDH1A1 P00352 8/20 0.97
▸ HSD17B10 Q99714 6/20 0.97
▸ HPGD P15428 1/20 0.97
▸ NPSR1 Q6W5P4 1/20 0.97
▸ POLB P06746 2/20 0.76
▸ GAA P10253 2/20 0.76
▸ ALOX12 P18054 1/20 0.76
▸ KMT2A Q03164 1/20 0.76
▸ TSHR P16473 2/20 0.69
▸ RECQL P46063 1/20 0.69
▸ SMN1; SMN2 Q16637 3/20 0.68
▸ MAPT P10636 1/20 0.65
▸ LMNA P02545 2/20 0.61
▸ CETP P11597 1/20 0.60
▸ HDAC3 O15379 1/20 0.60
▸ HDAC1 Q13547 1/20 0.60
▸ HDAC2 Q92769 1/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5062079 0.86 KDM4E (0.77) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL7733805 0.85 ALDH1A1 (0.71) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL21221137 0.83 ALDH1A1 (0.69) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL11732563 0.83 ALDH1A1 (0.68) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL7814976 0.83 ALDH1A1 (0.68) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL28728842 0.82 ALDH1A1 (0.68) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL12323604 0.82 CETP (0.77) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL28256535 0.82 CETP (0.77) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL28258088 0.82 CETP (0.77) KDM4EALDH1A1HSD17B10HPGDNPSR1
SCHEMBL14855625 0.82 ALDH1A1 (0.67) KDM4EALDH1A1HSD17B10HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2844345-B1 MODULATORS OF THE RELAXIN RECEPTOR 1 US HEALTH (US) 2022-08-03 — — EP disclosed
US-10125112-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2018-11-13 — — US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 — — US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 — — US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 — — US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 — — US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 — — US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 — — US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 — — US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 — — US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 — — US disclosed
EP-2844345-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 The United States of America, as Represented by The Secretary, Department of Health and Human Services (US) 2015-03-11 — — EP disclosed
WO-2013165606-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-11-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 RXFP1, RXFP2, RXFP3 KDM4E 4395/4885ALDH1A1 2561/4885HSD17B10 2635/4885
US-10125112-B2 Modulators of the relaxin receptor 1 RXFP1, RXFP2, RXFP3 KDM4E 4395/4885ALDH1A1 2561/4885HSD17B10 2635/4885
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 RXFP1, RXFP2, RXFP3 KDM4E 4395/4885ALDH1A1 2561/4885HSD17B10 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback